港股创新药概念股持续下跌 联邦制药跌超8%

Group 1 - The core viewpoint is that the Hong Kong innovative drug concept stocks are experiencing a continuous decline, with Federal Pharmaceutical dropping over 8% [1] - Other companies such as Crystal Technology Holdings, Giant Biologics, Sanofi Pharmaceutical, and China Biopharmaceutical are also following the downward trend [1]